Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002037809 | SCV002230110 | pathogenic | not provided | 2021-03-28 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Val74Trpfs*46) in the TYR gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TYR are known to be pathogenic (PMID: 23504663). This variant is not present in population databases (ExAC no frequency). This variant has been observed in individual(s) with clinical features of oculocutaneous albinism (PMID: 24721949, 30472657). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV003464292 | SCV004207602 | pathogenic | SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN | 2023-06-06 | criteria provided, single submitter | clinical testing | |
Juno Genomics, |
RCV004796690 | SCV005416693 | pathogenic | Tyrosinase-negative oculocutaneous albinism; Oculocutaneous albinism type 1B | criteria provided, single submitter | clinical testing | PM2_Supporting+PVS1+PM3+PP4 |